222 related articles for article (PubMed ID: 21520844)
1. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.
Hrycushko BA; Li S; Goins B; Otto RA; Bao A
Med Phys; 2011 Mar; 38(3):1339-47. PubMed ID: 21520844
[TBL] [Abstract][Full Text] [Related]
2. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.
French JT; Goins B; Saenz M; Li S; Garcia-Rojas X; Phillips WT; Otto RA; Bao A
J Vasc Interv Radiol; 2010 Aug; 21(8):1271-9. PubMed ID: 20478719
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.
Hrycushko BA; Gutierrez AN; Goins B; Yan W; Phillips WT; Otto PM; Bao A
Phys Med Biol; 2011 Feb; 56(3):703-19. PubMed ID: 21299006
[TBL] [Abstract][Full Text] [Related]
4. Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.
Hrycushko BA; Ware S; Li S; Bao A
Phys Med Biol; 2011 Sep; 56(17):5721-34. PubMed ID: 21841210
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
[TBL] [Abstract][Full Text] [Related]
6. Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.
Soundararajan A; Bao A; Phillips WT; McManus LM; Goins BA
Cancer Biother Radiopharm; 2011 Oct; 26(5):603-14. PubMed ID: 21834653
[TBL] [Abstract][Full Text] [Related]
7. Spatial dose distributions in solid tumors from 186Re transported by liposomes using HS radiochromic media.
Medina LA; Goins B; Rodríguez-Villafuerte M; Bao A; Martínez-Davalos A; Awasthi V; Galván OO; Santoyo C; Phillips WT; Brandan ME
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1039-49. PubMed ID: 17287961
[TBL] [Abstract][Full Text] [Related]
8. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
[TBL] [Abstract][Full Text] [Related]
9. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
[TBL] [Abstract][Full Text] [Related]
10. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Li XA; Wang JZ; Stewart RD; DiBiase SJ
Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
[TBL] [Abstract][Full Text] [Related]
12. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.
Bao A; Zhao X; Phillips WT; Woolley FR; Otto RA; Goins B; Hevezi JM
Med Phys; 2005 Jan; 32(1):200-8. PubMed ID: 15719971
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.
Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA
Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301
[TBL] [Abstract][Full Text] [Related]
14. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA
Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735
[TBL] [Abstract][Full Text] [Related]
15. 3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.
Ferrari ME; Cremonesi M; Di Dia A; Botta F; De Cicco C; Sarnelli A; Pedicini P; Calabrese M; Orecchia R; Pedroli G; Paganelli G
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1702-11. PubMed ID: 22890802
[TBL] [Abstract][Full Text] [Related]
16. Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection.
Bao A; Phillips WT; Goins B; Zheng X; Sabour S; Natarajan M; Ross Woolley F; Zavaleta C; Otto RA
Int J Pharm; 2006 Jun; 316(1-2):162-9. PubMed ID: 16580161
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Postema EJ; Börjesson PK; Buijs WC; Roos JC; Marres HA; Boerman OC; de Bree R; Lang M; Munzert G; van Dongen GA; Oyen WJ
J Nucl Med; 2003 Oct; 44(10):1690-9. PubMed ID: 14530488
[TBL] [Abstract][Full Text] [Related]
18. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
[TBL] [Abstract][Full Text] [Related]
19. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
Emfietzoglou D; Kostarelos K; Sgouros G
J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
[TBL] [Abstract][Full Text] [Related]
20. Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.
Kostarelos K; Emfietzoglou D
Anticancer Res; 2000; 20(5A):3339-45. PubMed ID: 11062762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
